Skip to main content
. 2016 Mar 2;18(3):219–239. doi: 10.1177/1098612X16631234

Table 10.

Considerations when selecting an antibacterial to treat urinary tract infections in cats with CKD

Consideration Action Antibacterials
Probably safe No dose adjustment required, due to wide therapeutic index or excretion via extrarenal routes Chloramphenicol
Penicillins (including clavulanate)
Consider dosage adjustment Adjust dose in moderate or severe CKD (IRIS stages 3 and 4) Cephalosporins (most)*
Fluoroquinolones
Sulphonamides (± trimethoprim)
Hazardous, avoid if possible Accumulation of drug or its metabolites in CKD can increase risk of adverse events Nalidixic acid
Nitrofurantoin
Tetracyclines (except doxycycline)
Nephrotoxic Avoid – high-risk drugs will exacerbate CKD Aminoglycosides
Polymyxins
*

Some cephalosporins accumulate in renal tubular cells and can cause damage

Avoid enrofloxacin in cats with CKD due to increased risk of retinopathy at standard therapeutic doses

Water soluble tetracyclines (eg, oxytetracycline) depend partly on renal excretion. Tetracyclines also increase protein catabolism, and breakdown products of oxytetracycline have been shown to be nephrotoxic

IRIS = International Renal Interest Society